NUTX
Nutex Health Inc.Price & Indicators
Blended from price, positioning & fundamentals · daily-close · not investment advice.
TL;DR.
AI-generated from the earnings call and 8-K · may contain errors · not investment advice
Technicals
trend & momentum for long-term holders BuyIllustrative technical + ownership context — a signal mix, not investment advice.
Key metrics
the company's own KPIs, from its earnings releases, calls, and filings| Metric | Latest | Period | YoY |
|---|---|---|---|
| Adjusted EBITDA attributable to Nutex Health non-GAAP | $57.6M | Q1 2026 | — |
| EBITDA attributable to Nutex Health non-GAAP | $68.3M | Q1 2026 | — |
| Net cash provided by operating activities | $75.5M | Q1 2026 | — |
| Total visits at the Hospital Division | 49,742 | Q1 2026 | — |
| Adjusted EBITDA non-GAAP | $57.6M | Q1 2026 call | — |
| Hospital division visits | 49,742 | Q1 2026 call | — |
| hospital facilities | 27 | as of Q1 2026 call | — |
| IDR prevailing rate | 85% | Q1 2026 call | — |
| same hospital visits growth | 0.6% | Q1 2026 call | — |
| same hospitals revenue growth | 0.2% | Q1 2026 call | — |
| total patient visits | 49,700 | Q1 2026 call | — |
Figures exactly as the company stated them · click a metric with a to chart its history · period links open the stating document · "call" marks figures stated on the earnings call, "filing" figures stated in the 10-K/10-Q · YoY needs the prior-year figure on file
Versus peers
Medical Care Facilities — same industry group| Company | Mkt cap | YTD | Rev growth Y/Y | P/E | Short % shares |
|---|---|---|---|---|---|
|
NUTX
this stock
Nutex Health Inc.
|
$1.29B | +14.1% | +82.4% | 13.8 | 16.2% |
|
HCA
HCA Healthcare, Inc.
|
$94.07B | -10.5% | +7.1% | 14.6 | 2.4% |
|
FSNUY
Fresenius SE & Co. KGaA
|
$28.14B | -12.8% | — | — | 0.0% |
|
THC
Tenet Healthcare Corp
|
$17.76B | +3.8% | -2.3% | 10.7 | 4.7% |
|
DVA
Davita Inc.
|
$15.13B | +107.5% | +6.5% | 22.0 | 7.2% |
Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding
At a glance
key data from every sectionPerformance
| 5D | 20D | 120D | MTD | YTD | |
|---|---|---|---|---|---|
| NUTX | +10.9% | +41.7% | +4.0% | +10.0% | +14.1% |
| SPY | +3.1% | -0.8% | +8.2% | +0.6% | +10.2% |
| vs SPY | +7.8% | +42.5% | -4.3% | +9.4% | +4.0% |
Capital returns
Dividends per share over the trailing 365 days by ex-date · buyback figures as last reported in SEC filings ("spent" derived as authorized − remaining; when several programs run concurrently, authorized is their combined total per the newest filing) · components shown separately — trailing-year buyback spend isn't tracked, so no combined shareholder yield is derived.